SCHEMBL835306

SCHEMBL835306

O=CCCC(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27275679 0.97
SCHEMBL832085 0.81
SCHEMBL834445 0.79
SCHEMBL28478024 0.77 TSHR (0.46)
SCHEMBL29011570 0.75
SCHEMBL706040 0.75
SCHEMBL17432055 0.75
SCHEMBL5618259 0.75
SCHEMBL20179681 0.72 HIF1A (0.44)
SCHEMBL1722348 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109771432-A Application of the aminoglucose carbohydrates and their derivative as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2019-05-21 CN claimed
CN-101575329-B Preparation method of tetrahydrothiophene-3-ketone and intermediate CHONGQING FUAN PHARMACEUTICAL CO LTD 2011-01-26 CN claimed
CN-101575329-A Preparation method of tetrahydrothiophene-3-ketone and intermediate CHONGQING FUAN PHARMACEUTICAL (CN) 2009-11-11 CN claimed
CN-114681472-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-06-30 CN disclosed
CN-114732822-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-06-30 CN disclosed
CN-114732823-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-05-23 CN disclosed
CN-114732822-A Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-07-12 CN disclosed
CN-114732823-A Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-07-12 CN disclosed
CN-114681472-A Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-07-01 CN disclosed
CN-109771432-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-04-19 CN disclosed
CN-112521350-A Synthetic method of 3-methylamino tetrahydrofuran 江苏广域化学有限公司 2021-03-19 CN disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed
EP-0542525-B1 Antithrombotic agents LILLY CO ELI (US) 1998-07-08 EP disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed
US-5250543-A Hypotensive agents LABORATOIRE L. LAFON (FR) 1993-10-05 US disclosed
EP-0415704-A2 Catalysts for polymerization of olefins CHISSO CORPORATION (JP) 1991-03-06 EP disclosed
EP-0105464-A2 Textile finishes SWS Silicones Corporation (US) 1984-04-18 EP disclosed